CJJD
Income statement / Annual
Last year (2024), China Jo-Jo Drugstores, Inc.'s total revenue was $154.54 M,
an increase of 3.85% from the previous year.
In 2024, China Jo-Jo Drugstores, Inc.'s net income was -$4.23 M.
See China Jo-Jo Drugstores, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
Operating Revenue |
$154.54 M
|
$148.81 M
|
$164.39 M
|
$133.13 M
|
$117.33 M
|
$107.55 M
|
$96.11 M
|
$81.50 M
|
$89.07 M
|
$76.90 M
|
Cost of Revenue |
$123.43 M |
$114.53 M |
$127.87 M |
$103.89 M |
$91.80 M |
$82.44 M |
$75.99 M |
$64.87 M |
$71.55 M |
$64.46 M |
Gross Profit |
$31.11 M |
$34.28 M |
$36.52 M |
$29.24 M |
$25.53 M |
$25.11 M |
$20.13 M |
$16.63 M |
$17.51 M |
$12.44 M |
Gross Profit Ratio |
0.2 |
0.23 |
0.22 |
0.22 |
0.22 |
0.23 |
0.21 |
0.2 |
0.2 |
0.16 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$7.26 M
|
$15.67 M
|
$8.19 M
|
$10.90 M
|
$8.11 M
|
$1.72 M
|
$17.82 M
|
$7.68 M
|
$5.18 M
|
$313,390.00
|
Selling & Marketing
Expenses |
$27.39 M
|
$29.18 M
|
$30.88 M
|
$26.95 M
|
$23.79 M
|
$24.27 M
|
$18.74 M
|
$12.92 M
|
$12.36 M
|
$10.42 M
|
Selling, General &
Administrative Expenses |
$34.64 M
|
$44.85 M
|
$39.06 M
|
$37.85 M
|
$31.90 M
|
$25.98 M
|
$36.56 M
|
$20.61 M
|
$17.54 M
|
$10.73 M
|
Other Expenses |
$0.00 |
$1.68 M |
$455,547.00 |
$176,519.00 |
-$204,064.00 |
-$93,311.00 |
$201,096.00 |
$19,888.00 |
-$43,535.00 |
$295,018.00 |
Operating Expenses |
$34.64 M |
$44.85 M |
$39.06 M |
$37.85 M |
$31.90 M |
$25.98 M |
$36.56 M |
$20.61 M |
$17.54 M |
$10.73 M |
Cost And Expenses |
$158.08 M |
$159.38 M |
$166.94 M |
$141.74 M |
$123.70 M |
$108.43 M |
$112.55 M |
$85.48 M |
$89.09 M |
$75.19 M |
Interest Income |
$516,637.00 |
$883,908.00 |
$401,921.00 |
$707,878.00 |
$1.06 M |
$112,887.00 |
$478,976.00 |
$379,790.00 |
$299,511.00 |
$0.00 |
Interest Expense |
$13,604.00 |
$65,854.00 |
$262,218.00 |
$455,187.00 |
$698,518.00 |
$241,837.00 |
$1.23 M |
$1,349.00 |
$155,578.00 |
$1.88 M |
Depreciation &
Amortization |
$5.38 M
|
$718,002.00
|
$1.26 M
|
$1.81 M
|
$2.08 M
|
$1.45 M
|
$1.38 M
|
$1.32 M
|
$1.46 M
|
$2.82 M
|
EBITDA |
$1.23 M
|
-$19.96 M
|
-$579,928.00
|
-$6.08 M
|
-$3.66 M
|
$266,561.00
|
-$15.05 M
|
-$4.24 M
|
$2.00 M
|
$4.53 M
|
EBITDA Ratio |
0.01 |
-0.05 |
-0 |
-0.04 |
-0.03 |
0.01 |
-0.15 |
-0.03 |
0.01 |
0.07 |
Operating Income Ratio
|
-0.02
|
-0.07
|
-0.02
|
-0.06
|
-0.05
|
-0.01
|
-0.17
|
-0.05
|
-0
|
0.02
|
Total Other
Income/Expenses Net |
-$636,817.00
|
$181,147.00
|
$446,455.00
|
$264,794.00
|
-$65,869.00
|
-$306,876.00
|
-$545,693.00
|
-$1.58 M
|
$568,663.00
|
-$795,158.00
|
Income Before Tax |
-$4.17 M |
-$20.74 M |
-$2.10 M |
-$8.34 M |
-$6.44 M |
-$1.18 M |
-$16.98 M |
-$5.56 M |
$543,897.00 |
$913,026.00 |
Income Before Tax Ratio
|
-0.03
|
-0.14
|
-0.01
|
-0.06
|
-0.05
|
-0.01
|
-0.18
|
-0.07
|
0.01
|
0.01
|
Income Tax Expense |
$62,862.00 |
$394,541.00 |
$1.10 M |
$31,638.00 |
$16,258.00 |
$134,763.00 |
$76,256.00 |
$84,387.00 |
$96,741.00 |
$57,398.00 |
Net Income |
-$4.23 M |
-$21.14 M |
-$3.20 M |
-$8.38 M |
-$6.46 M |
-$1.32 M |
-$17.06 M |
-$5.64 M |
$447,156.00 |
$856,557.00 |
Net Income Ratio |
-0.03 |
-0.14 |
-0.02 |
-0.06 |
-0.06 |
-0.01 |
-0.18 |
-0.07 |
0.01 |
0.01 |
EPS |
-2.93 |
-41.46 |
-220.62 |
-49.29 |
-47.23 |
-0.55 |
-8.16 |
-3.36 |
0.36 |
0.72 |
EPS Diluted |
-2.93 |
-41.46 |
-220.62 |
-49.29 |
-47.23 |
-0.55 |
-8.11 |
-3.32 |
0.36 |
0.72 |
Weighted Average Shares
Out |
$1.44 M
|
$509,827.00
|
$14,497.00
|
$169,919.00
|
$136,735.00
|
$2.41 M
|
$2.09 M
|
$1.68 M
|
$1.34 M
|
$1.25 M
|
Weighted Average Shares
Out Diluted |
$1.44 M
|
$509,827.00
|
$14,497.00
|
$169,919.00
|
$136,735.00
|
$2.41 M
|
$2.10 M
|
$1.70 M
|
$1.35 M
|
$1.26 M
|
Link |
|
|
|
|
|
|
|
|
|
|